Skip to content

KCS Wealth Advisory: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of KCS Wealth Advisory on GSK, newest first. How the timeline and the estimate are built.

KCS Wealth Advisory held 21,391 GSK shares at 2023-09-30 per its 13F-HR filed 2023-11-03.

the latest 13F is the newest step

  1. period ended2023-09-30
    13F 21,391 shares
    Change vs previous 13F +314 shares

    0.33% of the 13F portfolio, value $775,424.

    13F-HR 0001085146-23-004067 filed by KCS Wealth Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2023-06-30
    13F 21,077 shares
    Change vs previous 13F +862 shares

    0.26% of the 13F portfolio, value $751,184.

    13F-HR 0001085146-23-002737 filed by KCS Wealth Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-03-31
    13F 20,215 shares
    Change vs previous 13F +2,004 shares

    0.27% of the 13F portfolio, value $719,250.

    13F-HR 0001085146-23-001729 filed by KCS Wealth Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2022-12-31
    13F 18,211 shares
    Change vs previous 13F -5,795 shares

    0.27% of the 13F portfolio, value $639,935.

    13F-HR 0001085146-23-000755 filed by KCS Wealth Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2022-09-30
    13F 24,006 shares
    Change vs previous 13F not available

    0.33% of the 13F portfolio, value $706,000.

    13F-HR 0001085146-22-003532 filed by KCS Wealth Advisory
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).